Epcoritamab is designed to bind to CD3 on T cells and CD20 on B cells, inducing T cell mediated killing of CD20+ cells.
Most recent phase 3 trials of patients with newly diagnosed glioblastoma have shown no significant improvement in overall survival with the experimental treatment.
The MWF dosing option was approved under the Real-Time Oncology Review program based on data from the intramuscular administration part of a phase 2/3 trial.
As many as 10% of early-onset metastatic colorectal cancer cases may be attributable to undiagnosed inflammatory bowel disease, a study suggests.
Researchers sought to determine whether patients with PTCL who have a complete response after A+CHP would benefit from SCT.
Researchers sought to determine the landscape of BTK inhibitors for treating patients with CLL.
Dose-dense adjuvant chemotherapy improves disease-free survival in high-risk early breast cancer, according to updated results from the GIM2 trial.
Researchers sought to determine if automated standing orders for prophylaxis colony-stimulating factor would improve adherence to clinical guidelines for use according to risk for febrile neutropenia.
Results of a cross-sectional survey explain why patients with lung cancer may be reluctant to get involved in advocacy.
In a study of patients who had ever been diagnosed with kidney cancer, those who reported exercise or physical activity in the past 30 days had reduced likelihood of reporting worse physical and mental health.
A Plan-Do-Study-Act approach was used to validate a tool for measuring distress and clinical depression in patients with cancer.
The decision to restrict the indication follows an FDA review of the double-blind, placebo-controlled phase 3 ENGOT-OV16/NOVA trial.
The approval was based on data from the SORAYA trial.
A focus group sought to explore the effects of the changes in genitourinary cancer care during the COVID-19 pandemic from the perspective of patients and clinicians.
Investigators characterized the toxicity of stereotactic body radiotherapy for oligometastases from predominantly prostate, colorectal, breast, and lung cancer.
None of the YouTube or TikTok videos analyzed contained both high-quality and accurate information on prostate cancer screening.
Lung cancer among never-smokers is the 11th most common cancer among men and the 8th most common among women, a study suggests.
The approval was based on data from the open-label phase 3 AHOD1331 trial.
Findings showed that treatment with cemiplimab-rwlc plus platinum-based chemotherapy demonstrated a statistically significant improvement in overall survival.
A qualitative study sought to investigate the challenges faced by a surviving parent of dependent children after the cancer-related death of a co-parent.